TX SB1500

Authorizes the Medicaid medical director to issue standing written protocols for nonprescription drugs to improve Medicaid recipient access to preventive care during pregnancy, preconception, and postpartum periods

Requires written protocols to include pharmacy instructions, identify eligible recipient populations, list all known contraindications, and expire one year after issuance

Grants civil liability immunity to the medical director for issuing compliant written protocols and to health care providers who issue written protocols for nonprescription drugs that include known contraindications

Provides civil liability immunity to pharmacists, pharmacy technicians, and pharmacy technician trainees who dispense nonprescription drugs in accordance with the written protocols

Takes effect September 1, 2025, with implementation potentially delayed if federal waiver or authorization is required